Bedside Rules for Managing Acid-Base Derangement in Respiratory Failure: Applications to COVID-19

Respiratory failure is typically associated with changes in pCO2 leading to respiratory alkalosis (type 1 failure) and respiratory acidosis (type 2). As a compensatory response, plasma HCO3 concentration decreases if pCO2 decreases and increases conversely. These secondary responses prevent large pH fluctuations. However, metabolic acid-base disorders may still occur as a consequence of dysfunction of other organs and/or medical treatments. To recognize superimposed acid-base disorders, the availability of an accurate prediction of the expected HCO3 that corresponds to a given pCO2 is crucial. In chronic hypocapnia, the compensatory metabolic response is regulated by the equation ΔHCO3/ΔpCO2=0.4 mEq/L per mm Hg. An easy rule to compute the expected value of HCO3 may be 0.4×pCO2 +9. In chronic hypercapnia, the equation is ΔHCO3/ΔpCO2=0.48 mEq/L per mm Hg, and the expected value of HCO3 becomes 0.48×pCO2+4.74. While this expression is accurate, it seems to be of limited use for simple “bedside” predictions. In this contribution, we propose the simpler expression: the expected value of HCO3 in chronic hypercapnia=½ pCO2+3.5. For values of pCO2 not exceeding 70 mm Hg, with the proposed expression, the difference in HCO3 prediction in respect to the previous one is

Source: Clinical Pulmonary Medicine - March 1, 2020 Category: Respiratory Medicine Tags: Critical Care/Respiratory Care Source Type: research